🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether injections of Botulinum t...
Status
Completed
Location
Merz Investigational Site #043036
Start Date
2013-08
Trial ID
NCT01905683
Treatments Being Tested
The aim of this study is to confirm efficacy and safety of NT 201 (Xeomin®,...
Status
Completed
Location
Medizinische Hochschule Hannover (LKP)
Start Date
2007-09
Trial ID
NCT00541905
Treatments Being Tested
The purpose of this study is to determine whether a single treatment with a...
Status
Active Not Recruiting
Location
Physical Medicine and Rehabilitation at University of Alabama at Birmingham; Merz investigational site #0010479
Start Date
2019-09-16
Trial ID
NCT03992404
NT 201, also known as IncobotulinumtoxinA (Xeomin®/Bocouture®), is a Botuli...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00777803
Treatments Being Tested
Xeomin® is a Botulinum neurotoxin type A preparation free of complexing pro...
Status
Completed
Location
Merz Pharmaceuticals GmbH
Start Date
2007-08
Trial ID
NCT00515944
Treatments Being Tested
The objective of this Phase II study is to show that pre-treated patients w...
Status
Terminated
Location
Universitaets Augenklinik
Start Date
2007-08
Trial ID
NCT00507637
Treatments Being Tested
The purpose of this study is to determine whether injections of Botulinum t...
Status
Completed
Location
Merz Investigational Site #043037
Start Date
2013-06
Trial ID
NCT01893411
The purpose of this study is to assess the safety and efficacy of NT 201 co...
Status
Active Not Recruiting
Location
Merz Investigative Site
Start Date
2025-10-01
Trial ID
NCT07210463
Treatments Being Tested
In this clinical trial, participants with nerve pain after shingles or nerv...
Status
Completed
Location
Merz Investigational Site #3590004
Start Date
2023-11-22
Trial ID
NCT06091020
Treatments Being Tested
At baseline patients received incobotulinumtoxinA (Xeomin) or placebo. Ther...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00407030
Treatments Being Tested